Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 211
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07105371 Patients With ALS and Other Motor Disorders Will be Treated With Mesenc… |
Exosome Secretome | Sclérose latérale amyotrophique | Phase 1 | COMPLETED | En attente / non publié | The Foundation for Orthopaedics a… | Antigua and Barbuda · Medical Surgical Associates Cen… | 2024-07-14 → 2026-05-14 | Ouvrir |
| NCT06126315 ALCALS — Trial on the Biological and Clinical Effects of Acetyl-L-carni… |
Acetyl-l-carnitine | Sclérose latérale amyotrophique | Phase 2/3 | RECRUITING | En attente / non publié | Mario Negri Institute for Pharmac… | Australia, Italy · A.S.P. Palermo, Villa delle Ginest… | 2025-03-26 → 2027-09 | Ouvrir |
| NCT07862959 Early Access Program for Ulefnersen in Children, Adolescents and Adults… |
Ulefnersen | Sclérose latérale amyotrophique | À vérifier | AVAILABLE | En attente / non publié | Otsuka Pharmaceutical Development… | Non communiqué | Non communiqué | Ouvrir |
| NCT06249867 A Study to Assess the Safety, Tolerability, and Pharmacology of Darifen… |
Darifenacin 7.5 MG Extended Relea… | Sclérose latérale amyotrophique | Phase 2 | RECRUITING | En attente / non publié | Oliver Blanchard | Canada · Montreal Neurological Institute, Montreal, C… | 2024-11-08 → 2027-11 | Ouvrir |
| NCT07865260 PhiCube-Adults — PhiCube for Bilateral Upper Limb Neuromotor and Cognit… |
PhiCube | Sclérose latérale amyotrophique | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Istituto di Sistemi e Tecnologie … | Italy · Istituti Clinici Scientifici Maugeri IRCCS, B… | 2026-09 → 2027-09 | Ouvrir |
| NCT05163886 Study of Safety, Tolerability, and Biological Activity of LAM-002A in C… |
LAM-002A | Sclérose latérale amyotrophique | Phase 2 | COMPLETED | En attente / non publié | IRulya Therapeutics Inc. | United States · Johns Hopkins University School of Me… | 2021-12-23 → 2025-05-31 | Ouvrir |
| NCT07521930 Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT) |
INTENT Neural Interface System | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | Johns Hopkins University | United States · Johns Hopkins Medicine, Baltimore, Un… | 2027-01 → 2028-12 | Ouvrir |
| NCT04220190 RAPA-501 Therapy for ALS |
RAPA-501 Autologous T stem cells | Sclérose latérale amyotrophique | Phase 2/3 | RECRUITING | En attente / non publié | Rapa Therapeutics LLC | United States · Massachusetts General Hospital, Bosto… | 2025-01-02 → 2028-07-01 | Ouvrir |
| NCT05039099 A Study to Evaluate, Safety, Tolerability, and PK of AP-101 in Particip… |
AP-101 | Sclérose latérale amyotrophique | Phase 2 | COMPLETED | En attente / non publié | AL-S Pharma | United States, Belgium, Canada, Germany, South Korea,… | 2021-09-02 → 2025-08-13 | Ouvrir |
| NCT05936619 MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System |
Mind Extender (MindEx) | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | Nader Pouratian | United States · UT Southwestern Medical Center, Dalla… | 2026-02-20 → 2031-09-01 | Ouvrir |
| NCT07855211 HORIZON — A Study to Learn About the Safety of BIIB147 and Its Effects … |
BIIB147 | Sclérose latérale amyotrophique | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | Biogen | Non communiqué | 2026-10-22 → 2034-01-23 | Ouvrir |
| NCT06726577 TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Scleros… |
TP04HN106 | Sclérose latérale amyotrophique | Phase 1/2 | RECRUITING | En attente / non publié | Talengen Institute of Life Scienc… | China · The First Affiliated Hospital of Soochow Univ… | 2026-06-04 → 2027-04 | Ouvrir |
| NCT07204977 Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Late… |
Acamprosate calcium | Sclérose latérale amyotrophique | Phase 1 | RECRUITING | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2026-02-02 → 2028-09-30 | Ouvrir |
| NCT02880033 LymphoEnergy — Oxidative Stress and Apoptosis of Energy Metabolism by D… |
deferiprone | Sclérose latérale amyotrophique | Non applicable | COMPLETED | En attente / non publié | University Hospital, Lille | France · Hôpital Roger Salengro, CHRU de Lille, Lille… | 2011-02 → 2020-03 | Ouvrir |
| NCT05744310 ALS-LTMV — Effects of Long Term Ventilation Support on the Quality of L… |
Long term mechanical ventilation … | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | Haukeland University Hospital | Norway · Akershus University Hospital, Lørenskog, Nor… | 2023-04-21 → 2032-08-21 | Ouvrir |
| NCT06881979 Fit4MR-ChrMND — High-Tech Rehabilitation Pathway for Chronic Adult Neur… |
High-tech rehabilitative treatment | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | Istituti Clinici Scientifici Maug… | Italy · Azienda Ospedaliero-Universitaria di Modena, … | 2025-04-28 → 2026-11 | Ouvrir |
| NCT07833618 A Phase II Study of ALT001 in Patients With Amyotrophic Lateral Scleros… |
ALT001 1.0 μg/kg | Sclérose latérale amyotrophique | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Darwin Origin (Hubei) Biopharmace… | China · Capital Medical University Affiliated Beijing… | 2026-09-01 → 2028-12-31 | Ouvrir |
| NCT07082192 A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-… |
Test drug CB03-154 5mg group | Sclérose latérale amyotrophique | Phase 2/3 | RECRUITING | En attente / non publié | Shanghai Zhimeng Biopharma, Inc. | China · Peking University Third Hospital, Beijing, Ch… | 2025-10-30 → 2027-10 | Ouvrir |
| NCT07834450 CORTEX-ALS — Efficacy and Safety of Cyclophosphamide in Amyotrophic Lat… |
Cyclophosphamide | Sclérose latérale amyotrophique | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Hebei Senlang Biotechnology Inc.,… | Non communiqué | 2026-10-01 → 2029-09-30 | Ouvrir |
| NCT07836751 Using Gaze to Enable Head-neck Movements in Patients With Head Drop |
neck exoskeleton controller | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | University of Utah | United States · Utah Wearable Robotics Laboratory, De… | 2025-06-30 → 2026-12-01 | Ouvrir |
| NCT07838389 Evaluation of Donor-Derived B Cell Infusions in Patients With Amyotroph… |
B cell infusion | Sclérose latérale amyotrophique | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Mark Poznansky | United States · Sean M. Healey and AMG Center for ALS… | 2027-09 → 2030-01 | Ouvrir |
| NCT05407324 DAZALS — Dazucorilant in Patients With Amyotrophic Lateral Sclerosis |
Dazucorilant 300 mg | Sclérose latérale amyotrophique | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Corcept Therapeutics | United States, Belgium, Canada, France, Germany, Irel… | 2022-11-15 → 2027-11 | Ouvrir |
| NCT06441682 ReALiSe — A Safety and Efficacy Study of ARGX-119 in Adult Patients Wit… |
ARGX-119 | Sclérose latérale amyotrophique | Phase 2 | TERMINATED | En attente / non publié | argenx | Belgium, Canada, Denmark, France, Netherlands, Sweden… | 2024-10-23 → 2026-08-12 | Ouvrir |
| NCT05035823 COMMAND Early Feasibility Study: Implantable BCI to Control a Digital D… |
Motor Neuroprosthesis (MNP) | Sclérose latérale amyotrophique | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Synchron Medical, Inc. | United States · Mount Sinai Health System, New York, … | 2022-04-27 → 2028-09 | Ouvrir |
| NCT04396873 PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease |
11C-MC1 | Sclérose latérale amyotrophique | Phase 1 | RECRUITING | En attente / non publié | National Institute of Mental Heal… | United States · National Institutes of Health Clinica… | 2021-08-17 → 2030-10-03 | Ouvrir |